Skip to content

Clinical trials

Phase 4 Breast Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 4 Country / region: China Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20083
20101
20112
20133
20142
20153
20164
20181
20192
20214
20225
20234
20244
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status17
Completed14
Recruiting9
Not yet recruiting6
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital, Zhejiang University, School of Medicine4
Fudan University3
Nanjing Medical University3
Peking University2
Shandong Cancer Hospital and Institute2
Shandong University2
Shengjing Hospital2
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2
AstraZeneca1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms47
Agnosia1
Bone Neoplasms1
Carcinoma, Ductal, Breast1
Carcinoma, Non-Small-Cell Lung1
Cardiovascular Diseases1
Chemotherapy-Induced Febrile Neutropenia1
Colonic Neoplasms1
Coronary Disease1
Esophageal Neoplasms1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.